Key result
FFR-guided PCI reduces all-cause mortality ~21% compared to non-physiology-guided revascularization.
Why the study?
Recent studies comparing FFR-guided PCI with non-physiology-guided revascularization for intermediate coronary lesions have reported conflicting results.
Does FFR-guided PCI reduce mortality and adverse cardiac events in patients with coronary artery disease compared to non-physiology-guided revascularization?
Meta-Analysis (n=78,897)
Does FFR-guided PCI reduce mortality and adverse cardiac events in patients with coronary artery disease compared to non-physiology-guided revascularization?
FFR-guided PCI is associated with a significantly lower risk of all-cause mortality and myocardial infarction compared to non-physiology-guided revascularization strategies in patients with CAD.
Answers are grounded in this paper and cite their sources.
Supports FFR-guided PCI to reduce mortality in CAD; extends prior evidence in largest meta-analysis (N=78,897).
Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is recommended in revascularization guidelines for intermediate lesions. However, recent studies comparing FFR-guided PCI with non-physiology-guided revascularization have reported conflicting results. PubMed and Embase were searched for studies comparing FFR-guided PCI with non-physiology-guided revascularization strategies (angiography-guided, intracoronary imaging-guided, coronary artery bypass grafting). Data were pooled by meta-analysis using random-effects model. 26 studies enrolling 78,897 patients were included. FFR-guided PCI as compared to non-physiology-guided coronary revascularization had lower risk of all-cause mortality (odds ratio [OR] 0.79 95% confidence interval [CI] 0.64–0.99, I 2 = 53%) and myocardial infarction (MI) (OR 0.74 95% CI 0.59–0.93, I 2 = 44.7%). However, no differences between groups were found in terms of major adverse cardiac events (MACEs) (OR 0.86 95% CI 0.72–1.03, I 2 = 72.3%) and repeat revascularization (OR 1 95% CI 0.82–1.20, I 2 = 43.2%). Among patients with coronary artery disease (CAD), FFR-guided PCI as compared to non-physiology-guided revascularization was associated with a lower risk of all-cause mortality and MI.
No takes yet. Share an insight, caveat, or question.
Sanz‐Sánchez et al. (2023) conducted a meta-analysis in Coronary artery disease (n=78,897). Fractional flow reserve (FFR)-guided percutaneous coronary intervention vs. Non-physiology-guided revascularization (angiography-guided, intracoronary imaging-guided, CABG) was evaluated on All-cause mortality (OR 0.79, 95% CI 0.64-0.99). Fractional flow reserve (FFR)-guided percutaneous coronary intervention reduced the risk of all-cause mortality compared to non-physiology-guided revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: